Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer

LESSONS LEARNED: The biweekly GEM plus CBDCA dose and schedule showed satisfactory efficacy with mild toxicities in elderly patients with advanced NSCLC. The biweekly GEM plus CBDCA regimen could be considered an alternative to the 3‐week regimen in NSCLC. BACKGROUND: The gemcitabine (GEM)‐carboplat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Takayama, Koichi, Ichiki, Masao, Matsumoto, Takemasa, Ebi, Noriyuki, Akamine, Shinji, Tokunaga, Shoji, Yamada, Tadaaki, Uchino, Junji, Nakanishi, Yoichi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2019
Konular:
Clinical Trial Results
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066693/
https://ncbi.nlm.nih.gov/pubmed/32162814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0717
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller